Ray Dalio acquired 5.39 Thousand Haemonetics shares worth $367 Thousand. That's 0.00% of their equity portfolio (579th largest holding). The first Haemonetics trade was made in Q2 2021. Since then Ray Dalio bought shares five more times and sold shares on nine occasions. The stake costed the investor $362 Thousand, netting the investor a gain of 1.4% so far.